Topics regarding Regeneron Pharmaceuticals (REGN) stock

Topics regarding Regeneron Pharmaceuticals (REGN) stock

Expensive but worth it

Regeneron seems to be one of the most stable constant climbers lately. I know it's expensive right now, but in my opinion, well worth it. Just look at its latest earnings report. Plus, with products like Eylea and Dupixent, I don't think there's a... — read more 

by
| 62 views | | no replies yet
Post ID: @OP+1pvUH7V8

Start a new thread - post a news comment, question or message:

: